AstraZeneca has struck a $1bn (£773m) deal to buy a Belgian biotech company that specialises in cancer immunotherapies, the latest in a string of acquisitions that also yielded positive results for a late-stage rare disease drug on Monday.
EsoBiotec, a small privately held firm, develops in-vivo CAR-T cell therapies that empower the immune system to attack cancers, and could offer many more patients access to cell therapy treatments, provided in minutes rather than weeks.
The deal marks the latest acquisition by AstraZeneca, which is Britain’s biggest listed company valued at £184bn, as the pharmaceutical group continues to expand its global operations. Its share price fell by 1.2% on Monday afternoon.
Read Full Article Here
AstraZeneca pays up to $1bn for biotech firm ‘that could transform cell therapy’
- by: Julia Kollewe
- 03.17.25
- Source:
The Guardian
- 03/17/2025
Follow us
Read our latest news on any of these social networks!
Get latest news delivered daily!
We will send you breaking news right to your inbox
Have a tip? Let us know!
Recent Articles
- by: Steven Nelson
- Source:
NY Post
- 07/01/2025
Trump formally lifts Syria sanctions after meeting with ex-Al Qaeda fighter prez in Saudi Arabia
President Trump gave his final sign-off Monday to lifting longstanding US sanctions on Syria after pledging to do so last month during a trip to Saudi Arabia – in spite of the fact that the country’s new president, Ahmed al-Sharaa, is a former leader of al Qaeda.
- by: Mike Jenkins
- Source:
Tampa Fee Press
- 07/01/2025
U.S. Supreme Court To Review Limits On Coordinated Party Campaign Spending
The Supreme Court announced Monday it will hear a significant challenge to federal limitations on coordinated party campaign spending, a decision that could reshape how political parties support their candidates.
- by: AAMER MADHANI
- Source:
Daily record news
- 07/01/2025
CIA chief told lawmakers Iran nuclear program set back years with strikes on metal conversion site
CIA Director John Ratcliffe has told skeptical U.S. lawmakers that American military strikes destroyed Iran’s lone metal conversion facility and delivered a monumental setback to Tehran’s nuclear program that will take years to overcome
- by: Ryan King and Carl Campanile
- Source:
NY Post
- 06/30/2025
Zohran Mamdani doubles down on plan to target ‘whiter neighborhoods’ with higher taxes — and says billionaires shouldn’t exist
Socialist New York City mayoral candidate Zohran Mamdani doubled down Sunday on his plan to jack up property taxes on “richer and whiter neighborhoods” — while asserting billionaires shouldn’t exist.